儿童中枢神经系统肿瘤遗传易感性及进化痕迹:一项前瞻性5年人群为基础的全基因组测序研究
这项前瞻性人群为基础的研究对128例中枢神经系统肿瘤患儿进行胚系全基因组测序,并系统分析3543名近亲家系。13例(10%)携带已知癌症基因的致病性变异,这些患儿更可能患髓母细胞瘤(OR 5.9,CI 1.6-21.2)并发生同时性中枢神经系统肿瘤(P=0.01)。与儿童癌症高风险相关的基因在进化上受到更强约束。
要点
- 128例患儿中13例(10%)携带已知癌症基因的致病性变异。
- 携带致病性变异者更可能患髓母细胞瘤(OR 5.9,CI 1.6-21.2)并发生同时性中枢神经系统肿瘤(P=0.01)。
- 与儿童癌症高风险相关的基因在进化上比成人癌症风险基因受到更强约束(P=5e-4)。
核心结论
- 约10%的儿童中枢神经系统肿瘤可归因于已知癌症基因的罕见变异。
- 与儿童癌症高风险相关的基因显示出进化约束的证据。
研究设计与样本
- 前瞻性、人群为基础的研究,对128例中枢神经系统肿瘤患儿进行胚系全基因组测序。
- 辅以系统家系分析,覆盖3543名近亲。
主要发现
- 13例患儿(10%)携带已知癌症基因的致病性变异。
- 这些患儿更可能患髓母细胞瘤(OR 5.9,CI 1.6-21.2)并发生同时性中枢神经系统肿瘤(P=0.01)。
- 低级别胶质瘤患儿(12.8%)与高级别肿瘤患儿(12.2%)的携带频率相似。
- 与儿童癌症高风险相关的基因在进化上比成人恶性肿瘤风险相关基因受到更强约束(P=5e-4),也比所有其他基因受到更强约束(P=5e-17)。
- 在141456名人类中分析2986个高度进化约束基因,鉴定出8个直接致病的功能缺失变异,并显示约束程度与致病可能性之间存在剂量反应关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The etiology of central nervous system (CNS) tumors in children is largely unknown and population-based studies of genetic predisposition are lacking. METHODS: In this prospective, population-based study, we performed germline whole-genome sequencing in 128 children with CNS tumors, supplemented by a systematic pedigree analysis covering 3543 close relatives. RESULTS: Thirteen children (10%) harbored pathogenic variants in known cancer genes. These children were more likely to have medulloblastoma (OR 5.9, CI 1.6-21.2) and develop metasynchronous CNS tumors (P = 0.01). Similar carrier frequencies were seen among children with low-grade glioma (12.8%) and high-grade tumors (12.2%). Next, considering the high mortality of childhood CNS tumors throughout most of human evolution, we explored known pediatric-onset cancer genes, showing that they are more evolutionarily constrained than genes associated with risk of adult-onset malignancies (P = 5e-4) and all other genes (P = 5e-17). Based on this observation, we expanded our analysis to 2986 genes exhibiting high evolutionary constraint in 141,456 humans. This analysis identified eight directly causative loss-of-functions variants, and showed a dose-response association between degree of constraint and likelihood of pathogenicity-raising the question of the role of other highly constrained gene alterations detected. CONCLUSIONS: Approximately 10% of pediatric CNS tumors can be attributed to rare variants in known cancer genes. Genes associated with high risk of childhood cancer show evolutionary evidence of constraint.
引用
- Stoltze UK, Foss-Skiftesvik J, van Overeem Hansen T, et al. Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumors. Neuro Oncol. 2023. PMID: 35902210. doi:10.1093/neuonc/noac187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。